Shares of Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $18.20.
A number of analysts recently issued reports on BWAY shares. BTIG Research restated a “buy” rating and issued a $20.00 price target on shares of Brainsway in a research report on Thursday, September 10th. Wall Street Zen upgraded shares of Brainsway from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. HC Wainwright reissued a “buy” rating and issued a $19.00 target price on shares of Brainsway in a research note on Tuesday, September 8th. LADENBURG THALM/SH SH lifted their price target on shares of Brainsway from $18.00 to $18.80 and gave the stock a “buy” rating in a research note on Thursday, August 13th. Finally, Zacks Research cut Brainsway from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th.
View Our Latest Research Report on BWAY
Brainsway Price Performance
Brainsway (NASDAQ:BWAY – Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.04. The business had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.54 million. Brainsway had a net margin of 15.65% and a return on equity of 12.74%. On average, sell-side analysts expect that Brainsway will post 0.33 earnings per share for the current year.
Hedge Funds Weigh In On Brainsway
Several hedge funds have recently bought and sold shares of BWAY. Masters Capital Management LLC increased its holdings in Brainsway by 65.0% during the 1st quarter. Masters Capital Management LLC now owns 1,650,000 shares of the company’s stock worth $21,928,000 after purchasing an additional 650,000 shares during the period. Renaissance Technologies LLC lifted its holdings in shares of Brainsway by 87.2% in the 1st quarter. Renaissance Technologies LLC now owns 518,420 shares of the company’s stock worth $6,890,000 after buying an additional 241,560 shares during the period. Sei Investments Co. lifted its holdings in shares of Brainsway by 262.5% in the 1st quarter. Sei Investments Co. now owns 226,378 shares of the company’s stock worth $3,009,000 after buying an additional 163,925 shares during the period. Y.D. More Investments Ltd grew its position in shares of Brainsway by 136.6% during the 1st quarter. Y.D. More Investments Ltd now owns 272,004 shares of the company’s stock worth $3,615,000 after buying an additional 157,042 shares in the last quarter. Finally, Tidal Investments LLC grew its position in shares of Brainsway by 492.8% during the 2nd quarter. Tidal Investments LLC now owns 89,248 shares of the company’s stock worth $1,384,000 after buying an additional 74,193 shares in the last quarter. Institutional investors own 30.11% of the company’s stock.
Brainsway Company Profile
BrainsWay Ltd. is a medical technology company that develops and commercializes noninvasive treatments for brain disorders. Its primary technology, Deep Transcranial Magnetic Stimulation (Deep TMS), uses electromagnetic fields to stimulate targeted areas of the brain and is delivered through specialized treatment systems and helmet-like coils.
The company’s Deep TMS platform is used by healthcare providers in the treatment of major depressive disorder, obsessive-compulsive disorder and smoking addiction, subject to applicable regulatory clearances and local treatment guidelines.
Featured Stories
- Five stocks we like better than Brainsway
- NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks
Receive News & Ratings for Brainsway Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brainsway and related companies with MarketBeat.com's FREE daily email newsletter.
